Home › Trial NCT03449238
Pembrolizumab And Stereotactic Radiosurgery (Srs) Of Selected Brain Metastases In Breast Cancer Patients
- Trial IDNCT03449238
- StatusRecruiting
- PhasePhase 1/2
- Study typeInterventional
- SponsorWeill Medical College of Cornell University
- Enrollment41
- Start date2018-11-15
- ConditionsMetastatic Breast Cancer · Brain Metastases
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.